| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ERYTHROMYCIN | 216066 | 002 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 500MG | No | No | 2022/07/13 | 2022/07/13 | ALKEM LABS LTD | Prescription |
| ERYTHROMYCIN ETHYLSUCCINATE | 216212 | 001 | ANDA | ERYTHROMYCIN ETHYLSUCCINATE | GRANULE;ORAL | EQ 200MG BASE/5ML | No | No | 2022/11/21 | 2022/11/21 | CADILA PHARMS LTD | Prescription |
| ERYTHROMYCIN ETHYLSUCCINATE | 216212 | 002 | ANDA | ERYTHROMYCIN ETHYLSUCCINATE | GRANULE;ORAL | EQ 400MG BASE/5ML | No | No | 2022/11/21 | 2022/11/21 | CADILA PHARMS LTD | Prescription |
| ERYTHROMYCIN | 212693 | 001 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 250MG | No | No | 2023/03/07 | 2023/03/07 | ZYDUS LIFESCIENCES | Prescription |
| ERYTHROMYCIN | 212693 | 002 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 500MG | No | No | 2023/03/07 | 2023/03/07 | ZYDUS LIFESCIENCES | Prescription |
| ERYTHROMYCIN | 215661 | 001 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 250MG | No | No | 2023/08/24 | 2023/08/24 | ALEMBIC | Prescription |
| ERYTHROMYCIN | 215661 | 002 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 500MG | No | No | 2023/08/24 | 2023/08/24 | ALEMBIC | Prescription |
| ERYTHROMYCIN | 215440 | 001 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 250MG | No | No | 2023/08/31 | 2023/08/31 | ZYDUS PHARMS | Discontinued |
| ERYTHROMYCIN | 215440 | 002 | ANDA | ERYTHROMYCIN | TABLET;ORAL | 500MG | No | No | 2023/08/31 | 2023/08/31 | ZYDUS PHARMS | Discontinued |
| ERYTHROMYCIN LACTOBIONATE | 216761 | 001 | ANDA | ERYTHROMYCIN LACTOBIONATE | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No | 2024/11/19 | 2024/11/19 | GLAND PHARMA LTD | Prescription |